101 related articles for article (PubMed ID: 20371598)
1. Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration.
Brigotti M; Tazzari PL; Ravanelli E; Carnicelli D; Barbieri S; Rocchi L; Arfilli V; Scavia G; Ricci F; Bontadini A; Alfieri RR; Petronini PG; Pecoraro C; Tozzi AE; Caprioli A
J Leukoc Biol; 2010 Jul; 88(1):201-10. PubMed ID: 20371598
[TBL] [Abstract][Full Text] [Related]
2. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
[TBL] [Abstract][Full Text] [Related]
3. Interactions between Shiga toxins and human polymorphonuclear leukocytes.
Brigotti M; Carnicelli D; Ravanelli E; Barbieri S; Ricci F; Bontadini A; Tozzi AE; Scavia G; Caprioli A; Tazzari PL
J Leukoc Biol; 2008 Oct; 84(4):1019-27. PubMed ID: 18625912
[TBL] [Abstract][Full Text] [Related]
4. Shiga-toxin-induced firm adhesion of human leukocytes to endothelium is in part mediated by heparan sulfate.
Geelen J; Valsecchi F; van der Velden T; van den Heuvel L; Monnens L; Morigi M
Nephrol Dial Transplant; 2008 Oct; 23(10):3091-5. PubMed ID: 18469308
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome.
Brigotti M; Tazzari PL; Ravanelli E; Carnicelli D; Rocchi L; Arfilli V; Scavia G; Minelli F; Ricci F; Pagliaro P; Ferretti AV; Pecoraro C; Paglialonga F; Edefonti A; Procaccino MA; Tozzi AE; Caprioli A
Pediatr Infect Dis J; 2011 Jun; 30(6):486-90. PubMed ID: 21164386
[TBL] [Abstract][Full Text] [Related]
6. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.
Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA
Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor.
Arfilli V; Carnicelli D; Rocchi L; Ricci F; Pagliaro P; Tazzari PL; Brigotti M
Biochem J; 2010 Nov; 432(1):173-80. PubMed ID: 20809900
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli Shiga toxin.
Nakao H; Takeda T
J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
[TBL] [Abstract][Full Text] [Related]
9. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
[TBL] [Abstract][Full Text] [Related]
10. Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters.
King AJ; Sundaram S; Cendoroglo M; Acheson DW; Keusch GT
J Infect Dis; 1999 Feb; 179(2):503-7. PubMed ID: 9878039
[TBL] [Abstract][Full Text] [Related]
11. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.
Hurley BP; Thorpe CM; Acheson DW
Infect Immun; 2001 Oct; 69(10):6148-55. PubMed ID: 11553554
[TBL] [Abstract][Full Text] [Related]
12. [Activation of innate and specific immune responses in hemolytic uremic syndrome (HUS)-patients].
Palermo MS; Fernandez GC; Ramos MV; Bentancor L; Fernandez Brando R; Dran GI; Isturiz MA
Medicina (B Aires); 2006; 66 Suppl 3():16-21. PubMed ID: 17354472
[TBL] [Abstract][Full Text] [Related]
13. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils.
Brigotti M; Carnicelli D; Arfilli V; Tamassia N; Borsetti F; Fabbri E; Tazzari PL; Ricci F; Pagliaro P; Spisni E; Cassatella MA
J Immunol; 2013 Nov; 191(9):4748-58. PubMed ID: 24068665
[TBL] [Abstract][Full Text] [Related]
14. Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome.
Fernández GC; Rubel C; Barrionuevo P; López L; Ramirez F; Díaz M; Isturiz MA; Palermo MS
Pediatr Nephrol; 2002 May; 17(5):337-44. PubMed ID: 12042890
[TBL] [Abstract][Full Text] [Related]
15. Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.
Brigotti M; Carnicelli D; Arfilli V; Rocchi L; Ricci F; Pagliaro P; Tazzari PL; Vara AG; Amelia M; Manoli F; Monti S
J Biol Chem; 2011 Oct; 286(40):34514-21. PubMed ID: 21832076
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells.
Harrison LM; Cherla RP; van den Hoogen C; van Haaften WC; Lee SY; Tesh VL
Microb Pathog; 2005; 38(2-3):63-76. PubMed ID: 15748808
[TBL] [Abstract][Full Text] [Related]
17. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
[TBL] [Abstract][Full Text] [Related]
18. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.
Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M
Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.
Tazzari PL; Ricci F; Carnicelli D; Caprioli A; Tozzi AE; Rizzoni G; Conte R; Brigotti M
Cytometry B Clin Cytom; 2004 Sep; 61(1):40-4. PubMed ID: 15351981
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome.
Pysher TJ; Siegler RL; Tesh VL; Taylor FB
Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
